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E-mail address: dglee222@knu.ac.kr (D.G. Lee).Antifungal effects of nuclear entry inhibitory signal peptide of HIV-1 Rev protein (Rev-NIS) were
investigated. Rev-NIS contained potent antifungal activities without hemolytic effects. To under-
stand the antifungal mechanism(s), in vivo and in vitro ﬂuorescent studies were conducted. Flow
cytometric analysis with bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] and calce-
in-leakage measurement from large unilamellar vesicles (LUVs) indicated that Rev-NIS depolarized
and disrupted the fungal membranes. These results were further conﬁrmed by using giant unilamel-
lar vesicles (GUVs). The current study suggests that Rev-NIS exerts its antifungal activity with mem-
brane-active mechanism(s).
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A rapid and radical increase in the emergence of antibiotics-
resistant microbes has occurred in recent years [1]. This has not
only made treatment for infectious diseases more problematic,
but has also resulted in the reappearance of many diseases thought
to be under control. To solve these problems, new antibiotics has
become inevitable and urgent [2]. Antimicrobial peptides (AMPs)
are thought to be novel model regarding therapeutic agents. In
contrast to conventional antibiotics, AMPs rapidly permeate and
disrupt the cell membrane, causing damage hard to repair. There-
fore, microbial resistance may occur with much lower probability
than that observed with available antibiotics [3]. At this point in
time, development and improvement of novel antimicrobial pep-
tides are indispensable and crucial.
Human immunodeﬁciency virus type-1 (HIV-1) encoded the
regulatory protein, Rev, which is constantly shuttling between
the cell nucleus and the cytoplasm in the host cells, under the
control of a signal-mediated active import and export system,
probably over the support of the NIS (nuclear entry inhibitory sig-chemical Societies. Published by E
ignal peptide of Rev protein;
H-tetrazolium bromide;
e oxonol; LUVs, large unila-
PC, phosphatidylcholine; PE,nal) function [4–7]. Without NIS, Rev may migrate back through
the nuclear pore against the well-controlled nucleo-cytoplasmic
shuttling to complete its role in each compartment. Residues
11–20 of the NIS (Rev-NIS, ELLKAVRLIK) especially are comprised
of the conserved hydrophilicity motif, which forms an amphi-
pathic helix. Signiﬁcantly, this motif and its helical structure were
thought to be critical regarding the function of NIS as well as Rev
[8]. Although nuclear entry inhibitory signal peptide of Rev pro-
tein (Rev-NIS) had a noteworthy potential as an antimicrobial
peptide, its antimicrobial properties had not yet been studied.
In this study, the antifungal activity and its mechanism(s) of
Rev-NIS were investigated.
2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized by the solid phase method using 9-
ﬂuorenyl-methoxycarbonyl chemistry [9]. The crude peptides
were repeatedly washed with diethylether, dried in a vacuum,
and puriﬁed using a reversed-phase preparative HPLC on a Waters
15-lm Deltapak C18 column (19  30 cm). The purity of the pep-
tides was checked by an analytical reversed-phase HPLC on an
Ultrasphere C18 column (4.6  25 cm; Beckman, Fullerton, CA,
USA). The molecular weights of the synthetic peptides were deter-
mined using a matrix-assisted laser desorption ionization MALDI-
mass spectrometer [10].lsevier B.V. All rights reserved.
Table 1
Antifungal activity of Rev-NIS.
Peptide MIC (lM)
C. albicans C. parapsilosis M. furfur T. beigelii
Rev-NIS 10 10 20 20–40
Melittin 2.5 2.5 5 5
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Candida albicans (ATCC 90028) and Candida parapsilosis (ATCC
22019) were both obtained from the American Type Culture Col-
lection (ATCC) (Manassas, VA, USA). Malassezia furfur (KCTC
7744) and Trichosporon beigelii (KCTC 7707) were obtained from
the Korean Collection for Type Cultures (KCTC) of the Korea Re-
search Institute of Bioscience and Biotechnology (KRIBB), Daejeon,
Korea. Fungal cells were cultured in YPD broth (Difco) with aera-
tion at 28 C. M. furfur was cultured at 32 C in modiﬁed Bacto
yeast extract/malt extract (YM) broth (Difco) containing 1% olive
oil. Fungal cells (2  104 cells/ml) were inoculated into either
YPD or YM broth and 0.1 ml/well of the mixture was dispensed
into microtiter plates. Minimum inhibitory concentration (MIC)
was determined by means of a serial twofold dilution of the pep-
tides, following the micro-dilution method and MTT (3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay
[11]. After 48 h of incubation at either 28 C or 32 C, the minimal
peptide concentration to prevent the growth of a given test organ-
ism was determined and deﬁned as MIC. Growth was assayed with
microtiter ELISA Reader by monitoring absorption at 580 nm. MIC
values were determined by three independent assays.
2.3. Kinetics of fungal killing
Exponential phased C. albicans (ATCC 90028) cells (2106 CFUs/
ml) were incubated with either Rev-NIS or melittin (at the MIC).
The cultures were obtained and spread on an YPD agar plate, and
then the colony forming units (CFUs) were counted after incuba-
tion for 24 h at 28 C [12]. The values represented the average of
triplicate measurements in three independent assays.
2.4. Hemolytic activity
The hemolytic activity of the peptides was evaluated by deter-
mining the release of hemoglobin from a 4% suspension of fresh
human erythrocytes at 414 nm with an ELISA plate Reader [11].
The hemolysis percentage was calculated by using the following
equation: Percentage hemolysis = [(Abs414 nm in the peptide solu-
tion  Abs414 nm in PBS)/(Abs414 nm in 0.1% Triton X-
100  Abs414 nm in PBS)]  100 [13].
2.5. Changes of the plasma membrane potential
For analysis of the membrane integrity after the peptide treat-
ment, log-phased cells of C. albicans (1  108 cells) were harvested
and resuspended with 1 ml fresh YPD media, containing either
Rev-NIS or melittin (at the MIC). After incubation for 3 h, the cells
were washed with PBS. To detect the depolarization of the cell
membrane, 1 ml of PBS, containing 50 lg of bis-(1,3-dibutylbarbi-
turic acid) trimethine oxonol (DiBAC4(3); Molecular Probes,
Eugene, OR, USA), was added and then the samples were incubated
for 1 h at 4 C in darkness [14]. Flow cytometric analysis was con-
ducted by means of a FACSCalibur ﬂow cytometer (Becton Dickin-
son, San Jose, CA, USA).
2.6. Calcein leakage measurement
Calcein-encapsulated large unilamellar vesicles (LUVs), com-
posed of phosphatidylcholine(PC)/phosphatidylethanolamine(PE)/
phosphatidylinositol(PI)/ergosterol (5:4:1:2, w/w/w/w), were pre-
pared by vortexing the dried lipids in a dye buffer solution
(70 mM calcein, 10 mM Tris, 150 mM NaCl, and 0.1 mM EDTA
[pH 7.4]). The suspension was frozen-thawed in liquid nitrogen
for 11 cycles and extruded through polycarbonate ﬁlters (two
stacked 100 nm pore size ﬁlters) by a LiposoFast extruder (AvestinInc., Ottawa, Canada). Untrapped calcein was removed by a gel ﬁl-
tration process on a Sephadex G-50 column. The leakage of calcein
from the LUVs was monitored by measuring the ﬂuorescent inten-
sity, at an excitation wavelength of 490 nm and an emission wave-
length of 520 nm, with a RF-5301PC spectroﬂuorophotometer
(Shimadzu, Kyoto, Japan). The measurements were conducted at
25 C. For determination of 100% dye release, 20 ll of 10% Triton
X-100 was added to the vesicles. The percentage of dye leakage
caused by the peptides was calculated as follows: dye leakage
(%) = 100  (F  F0)/(Ft  F0), where F represents the ﬂuorescent
intensity achieved by the peptides and F0 and Ft represent the ﬂuo-
rescent intensities without the peptides and with Triton X-100,
respectively [15].
2.7. Formation and microscopic observation of GUVs
Giant unilamellar vesicles (GUVs) were prepared by using ITO
(indium tin oxide) glasses. Lipids were prepared at a concentration
of 3.75 mg/ml in chloroform. The lipid solutions (100–200 ll) were
deposited in a spin coater (Spin Coater, ACE-1020 Series) and the
glass was coated for 2 min. Then the coated ITO glass was evapo-
rated under a vacuum for 2 h. The following procedure was used
in succession; a square frame was created from silicon served as
a thickness (2 mm) spacer between the lipid-coated glass and nor-
mal glass. The chamber was ﬁlled with 10 mM HEPES buffer (pH
7.2) through a hole in the silicon spacer. Immediately, the applica-
tion of 1.7 V (peak-to-peak, sine wave) and 10 Hz to the ITO elec-
trodes was made by using a sweep function generator (Protek,
SWEEP FUNCTION GENERATOR 9205C) for 2 h. GUVs from the
ITO glass were then detached in conditions of 4 V (peak-to-peak)
and at 4 Hz for 10 min. Rev-NIS (at the MIC) was treated and
changes of GUVs were observed by using an inverted ﬂuorescence
phase contrast microscope (Leica, DFC420C).
3. Results and discussion
Peptides were chemically synthesized and the antifungal effects
of Rev-NIS were investigated. In this study, melittin was used as a
positive control. Melittin (GIGAVLKVLTTGLPALISWIKRKRQQ-NH2)
is the well-known antimicrobial peptide from the venom of the
honey bee Apis mellifera [16]. It was suggested that melittin formed
pores and translocated the membrane [17]. The result showed that
the fungal strains, as tested, were susceptible to Rev-NIS, with MIC
values in 10–40 lM range, while melittin had determined at MIC
values of 2.5–5 lM (Table 1). Furthermore, the kinetic fungal kill-
ing assay conducted with C. albicans indicated that the antifungal
activity of Rev-NIS might be due to cidal, rather than static action
(Fig. 1). Although most antimicrobial peptides exhibited good cell
selectivity among microbial and mammalian host cells, some anti-
microbial peptides showed lytic activities toward mammalian cells
[13]. Therefore, we investigated the hemolytic effects of Rev-NIS as
an indicator of its cytotoxicity to mammalian cells. The result
showed that Rev-NIS did not cause hemolysis on human erythro-
cytes, while melittin induced much more potent hemolytic activi-
ties at most tested concentration levels (Table 2). Although Rev-NIS
exhibited less potent antifungal activity than melittin, which
showed both potent antifungal and hemolytic activity, these
Fig. 1. Time killing plots for C. albicans by 10 lM of Rev-NIS or 2.5 lM of melittin.
The error bars represent the standard deviation (S.D.) values for three independent
experiments, performed in triplicate.
Table 2
Hemolytic activity of Rev-NIS against human erythrocytes.
Peptide % Hemolysis (lM)
100 50 25 12.5 6.25 3.13 1.56
Rev-NIS 0 0 0 0 0 0 0
Melittin 100 100 100 100 100 98 98
Fig. 3. Calcein leakage from LUVs in the presence of various concentrations (2.5, 5,
10, 20 lM) of the peptides. The error bars represent the standard deviation (S.D.)
values for three independent experiments, performed in triplicate.
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between fungal cells and mammalian cells. Also, it was suggested
that Rev-NIS could be applied to therapeutic agents regarding fun-
gal diseases in humans.
To understand the mechanism(s) of Rev-NIS for exerting anti-
fungal activities, C. albicans, both a commensal and opportunistic
pathogen of ever-increasing medical importance [18], was se-
lected. To investigate whether Rev-NIS can affect C. albicans, the
potential dissipation of the plasma membrane was examined by
staining with DiBAC4(3), a translational membrane potential dye
[19,20]. DiBAC4(3) contains a high voltage sensitivity and can enter
depolarized cells, where it binds to lipid-rich intracellular compo-
nents [14]. The result showed that Rev-NIS caused signiﬁcant accu-
mulations of DiBAC4(3) (Fig. 2). This indicated that Rev-NIS
affected fungal cells by damaging their membranes, thus disrupt-
ing the fungal membrane potential.Fig. 2. FACScan analysis of DiBAC4(3) staining in C. albicans. Histograms showed the ﬂ
Rev-NIS or 2.5 lM of melittin.Finally, to conﬁrm the membrane-disruptive mechanism(s) of
Rev-NIS, the effects of Rev-NIS on calcein-entrapped LUVs and
GUVs containing rhodamine-conjugated PE were examined, which
were composed of PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w), mim-
icking the membranes of C. albicans [21]. The calcein leakage per-
centage was measured to assess its ability to permeabilize the
membrane. GUVs, of which the diameters exceed 10 lm, have
been used for physical and biological investigations, such as the
elastic properties of phospholipid membranes [22,23], the chang-
ing shapes of vesicles [24–27], the interaction of cytoskeleton pro-
teins with the membranes [28], membrane fusion [29], and the
reconstitution of artiﬁcial cells [30,31]. These studies are useful
in understanding the dynamics of biomembranes [32]. The result
showed that Rev-NIS signiﬁcantly disrupted the liposome and
caused calcein-leakage from the LUVs (Fig. 3). Also, rhodamine
concentrations of the GUV progressively decreased after the addi-
tion of Rev-NIS (Fig. 4). These indicated that Rev-NIS exerted dye-
leakage from liposomes due to disruption of the fungal model
membranes. These results may also conﬁrm the membrane-active
mechanism of Rev-NIS.
In this study, the antimicrobial effects of Rev-NIS were investi-
gated. Although the exact mechanism(s) of Rev-NIS have not been
fully elucidated, this study suggests that Rev-NIS contains consid-
erable antifungal activities for regarding disruption of the fungal
plasma membranes.uorescent intensity of stained DiBAC4(3) in C. albicans after treatment of 10 lM of
Fig. 4. Phase contrast images of GUVs, labeled with rhodamine, induced by 10 lM of Rev-NIS. The times above each image show the time after the addition of peptide. The
bar corresponds to 10 lm.
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